A securities fraud class action lawsuit has been filed against PROCEPT BioRobotics Corporation on behalf of investors who purchased or acquired common stock between February 28, 2024 and February 25, 2026. The complaint alleges the company used an undisclosed discount program to incentivize bulk orders that exceeded actual demand, artificially inflating reported U.S. handpiece unit sales and exposing PROCEPT to material risks of operational and financial harm. On February 25, 2026, PROCEPT disclosed that handpiece sales had materially exceeded procedures every quarter since the first fiscal quarter of 2023, causing the stock to fall more than 18%. Investors have until September 22, 2026 to seek lead plaintiff status in the case, which is captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation in the U.S. District Court for the Northern District of California.
